English | Español

Ohio State Health & Discovery
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Sudden cardiac arrest in young athletes prompts focus on prevention and research
+ Pharmaceuticals
Patient Daily | Feb 23, 2026

Quad-sparing knee replacement offers faster recovery at Ohio State Wexner Medical Center
+ Pharmaceuticals
Patient Daily | Feb 17, 2026

Preventive measures aim to reduce artificial joint infections after replacement surgeries
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Tackling orthopedic joint infections remains critical for patient recovery
+ Pharmaceuticals
Patient Daily | Feb 11, 2026

Lifelong learning linked to improved well-being among older adults at Ohio State
+ Pharmaceuticals
Patient Daily | Feb 10, 2026

CoolSculpting offers non-surgical option for targeted fat reduction at Ohio State Wexner Medical Center
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

How consumers can identify credible sources for evidence-based health decisions
+ Pharmaceuticals
Patient Daily | Jan 30, 2026

Ohio State experts warn against routine use of biotin supplements after cancer

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation